scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding scPharmaceuticals Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 95 | 1 | 86 | −8 |
| Shares | 37.3M | 80.7K | 39.8M | +2.60M (+7.0%) |
| Value | $169.8M | $368.0K | $140.8M | −$28.6M (−16.9%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held scPharmaceuticals Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perceptive Advisors LLC | 500,000 | $1.77M | 0.05% |
| Raymond James Financial Inc | 89,690 | $317.5K | 0.00% |
| Johnson Financial Group, LLC | 85,184 | $301.6K | 0.04% |
| Wealthedge Investment Advisors, LLC | 19,380 | $68.6K | 0.03% |
| SG Americas Securities, LLC | 18,558 | $66.0K | 0.00% |
| Price T Rowe Associates Inc | 15,143 | $54.0K | 0.00% |
| ProShare Advisors LLC | 13,465 | $47.7K | 0.00% |
| Intech Investment Management LLC | 12,966 | $45.9K | 0.00% |
| China Universal Asset Management Co., Ltd. | 10,610 | $37.6K | 0.00% |
| Legato Capital Management LLC | 10,314 | $36.5K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 5,708 | $20.2K | 0.00% |
| R Squared Ltd | 3,492 | $12.4K | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,668 | $5.71K | 0.00% |
| GF Fund Management Co. Ltd. | 1,051 | $3.72K | 0.00% |
| SBI Securities Co., Ltd. | 297 | $1.05K | 0.00% |
| Caitong International Asset Management Co., Ltd | 267 | $945 | 0.00% |
| EverSource Wealth Advisors, LLC | 46 | $163 | 0.00% |
| IFP Advisors, Inc | 0 | $81 | 0.00% |
Sold out (26)
Institutions that held scPharmaceuticals Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
Not filed for Q4 2024 yet (1)
Institutions that held scPharmaceuticals Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 80,706 | $368.0K |